Refuge Biotechnologies
Menlo Park
About Refuge Biotechnologies
Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.9M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2018)
- Website: refugebiotech.com
Industries & Categories
Biotechnology, Genetics, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/refuge-biotechnologies-182272 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.